American Oncology Network, Inc.

OTCPK:AONC Stock Report

Market Cap: US$212.3m

American Oncology Network Management

Management criteria checks 1/4

American Oncology Network's CEO is Todd Schonherz, appointed in Apr 2021, has a tenure of 3.75 years. total yearly compensation is $2.25M, comprised of 32% salary and 68% bonuses, including company stock and options. directly owns 1.13% of the company’s shares, worth $2.39M. The average tenure of the management team and the board of directors is 2.6 years and 1.3 years respectively.

Key information

Todd Schonherz

Chief executive officer

US$2.2m

Total compensation

CEO salary percentage32.0%
CEO tenure3.8yrs
CEO ownership1.1%
Management average tenure2.6yrs
Board average tenure1.3yrs

Recent management updates

Recent updates

These 4 Measures Indicate That American Oncology Network (NASDAQ:AONC) Is Using Debt Extensively

Mar 22
These 4 Measures Indicate That American Oncology Network (NASDAQ:AONC) Is Using Debt Extensively

CEO Compensation Analysis

How has Todd Schonherz's remuneration changed compared to American Oncology Network's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$15m

Jun 30 2024n/an/a

-US$4m

Mar 31 2024n/an/a

-US$17m

Dec 31 2023US$2mUS$719k

-US$9m

Sep 30 2023n/an/a

-US$4m

Jun 30 2023n/an/a

US$0

Mar 31 2023n/an/a

US$6m

Dec 31 2022US$919kUS$698k

US$0

Sep 30 2022n/an/a

-US$8m

Dec 31 2021US$706kUS$682k

US$0

Compensation vs Market: Todd's total compensation ($USD2.25M) is above average for companies of similar size in the US market ($USD1.38M).

Compensation vs Earnings: Todd's compensation has increased whilst the company is unprofitable.

CEO

Todd Schonherz (54 yo)

3.8yrs

Tenure

US$2,249,491

Compensation

Mr. Todd Schonherz serves as Chief Executive Officer at American Oncology Network, Inc. since April 01, 2021 and serves as its Director since September 20, 2023. Mr. Schonherz served as Chief Operating Off...

Leadership Team

NamePositionTenureCompensationOwnership
Todd Schonherz
CEO & Director3.8yrsUS$2.25m1.13%
$ 2.4m
Stephen Divers
Chief Medical Officer4.5yrsUS$1.70m0.50%
$ 1.1m
David Afshar
Principal Accounting Officerless than a yearno data0.55%
$ 1.2m
Mark Moch
Chief Information Officerno datano datano data
Kristin Matisziw
Chief Compliance & Risk Officerno datano datano data
Erica Mallon
General Counselno datano datano data
Caroline Hewitt
Vice President of Marketingno datano datano data
Karen Quick
Vice President of Human Resourcesless than a yearno datano data
James Gilmore
Chief Pharmacy & Clinical Services Officer3.5yrsno datano data
Karen Pilley
Chief Revenue Cycle Officer2.6yrsno datano data
Anthony Belott
Chief Development Officer2yrsno datano data
Steven Swart
Executive Vice President of Practice Operationsno datano datano data

2.6yrs

Average Tenure

51yo

Average Age

Experienced Management: AONC's management team is considered experienced (2.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Todd Schonherz
CEO & Director1.3yrsUS$2.25m1.13%
$ 2.4m
Stephen Divers
Chief Medical Officer4.5yrsUS$1.70m0.50%
$ 1.1m
Bradley Fluegel
Independent Director1.3yrsno data0.17%
$ 352.5k
James Stith
Independent Director1.3yrsno datano data
Ravi Sarin
Independent Director1.3yrsno datano data
Ralph Boccia
Member of Advisory Boardno datano datano data
George Negrea
Member of Advisory Boardno datano datano data
Ram Trehan
Member of Advisory Boardno datano datano data
Jay Sidloski
Member of Advisory Boardno datano datano data
Taral Patel
Member of Advisory Board Executive Committeeno datano datano data
Jeanna Knoble
Member of Advisory Boardno datano datano data
Raja Mehdi
Member of Advisory Boardno datano datano data

1.3yrs

Average Tenure

50yo

Average Age

Experienced Board: AONC's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 11:47
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

American Oncology Network, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution